Showing results (11-20 of 62) with videos related to

Sort By:
Pageof 7
Emerging Infectious Diseases|February 7, 2022
Amplification Artifact in SARS-CoV-2 Omicron Sequences Carrying P681R Mutation, New York, USAAdriana Heguy, Dacia Dimartino, Christian Marier, et al.
NPJ Vaccines|May 7, 2026
A comparison of two- and three-dose MVA-BN mpox vaccination series on anti-monkeypox virus immunityAaron L Oom, Kesi K Wilson, Stephanie Rettig, et al.
Biorxiv : the Preprint Server for Biology|November 23, 2022
In-silico docking platform with serine protease inhibitor (SERPIN) structures identifies host cysteine protease targets with significance for SARS-CoV-2Joaquín J Rodriguez Galvan, Maren de Vries, Shiraz Belblidia, et al.
The EMBO Journal|September 9, 2025
Host cell and viral protease targets of human SERPINs identified by in silico dockingJoaquin Rodriguez Galvan, Maren de Vries, Shiraz Belblidia, et al.
Ebiomedicine|October 22, 2023
Selective adaptation of SARS-CoV-2 Omicron under booster vaccine pressure: a multicentre observational studyRalf Duerr, Dacia Dimartino, Christian Marier, et al.
Research Square|April 10, 2026
A Human Lymph node-on-a-Chip for Personalized Evaluation of Vaccine ImmunogenicityWeiqiang Chen, Fanghao Shi, Dongdong Liu, et al.
Cells|October 14, 2022
HIV-1 Infection of Long-Lived Hematopoietic Precursors In Vitro and In VivoSebastian Renelt, Patrizia Schult-Dietrich, Hanna-Mari Baldauf, et al.
Plos Pathogens|May 20, 2021
Dispersal dynamics of SARS-CoV-2 lineages during the first epidemic wave in New York CitySimon Dellicour, Samuel L Hong, Bram Vrancken, et al.
Medrxiv : the Preprint Server for Health Sciences|December 15, 2021
Clinical and genomic signatures of rising SARS-CoV-2 Delta breakthrough infections in New YorkRalf Duerr, Dacia Dimartino, Christian Marier, et al.
Ebiomedicine|July 29, 2022
Clinical and genomic signatures of SARS-CoV-2 Delta breakthrough infections in New YorkRalf Duerr, Dacia Dimartino, Christian Marier, et al.
Pageof 7